Table: begin end state 1 23 cytoplasmic 24 42 transmembrane 43 65 non-cytoplasmic 66 89 transmembrane 90 101 cytoplasmic 102 124 transmembrane 125 175 non-cytoplasmic 176 197 transmembrane 198 217 cytoplasmic 218 238 transmembrane 239 249 non-cytoplasmic 250 275 transmembrane 276 289 cytoplasmic 290 308 transmembrane 309 324 non-cytoplasmic 325 347 transmembrane 348 355 cytoplasmic 356 378 transmembrane 379 382 non-cytoplasmic 383 406 transmembrane 407 449 cytoplasmic
Input: >Echvi_3159 MFDTEIKSLKSLNHYLLKLVESRLWLKVIIALLLGVGFGLLLSPQNGWISKETADIAGNW LALPGVLFLKLVQMIMIPLIVASIITGIASNDKDSLKKLGGGVLLYFLGTTIVSVSIGTI LSQIFRPGRFLHQQALKEHNEITAVSTDEPELSFGVETIPDAISNLLPENPLASMVSGEM LSIVIFTIIIGVAVLSLENDLLRPVKLLLSAIQEVCMTVVKWSMLLVPIAVFGLMAQLTS SVGLSSLSGLTYYVGVVLLGLLFLVIFYLGLIVLLGKANPMHFLKKIRDVQLLAFSTTSS AAVMPLSLQTAEEKLKVDKTISNFIIPIGATVNMDGTALYQTITTLFIAQAYGLEMSLLN IIVVIVTIVAASIGTPAIPGGGVVILASVLGSVGIPAEGIIIIIGVERLLGMFRTAVNVM GDLTACMVFNRLYDIKILKFLKKKLYNYG
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server